[L-carnitine investigation and fish odor syndrome: an unwaited adverse effect] [PMID: 21481905] Laboratory literature summary: [L-carnitine investigation and fish odor syndrome: an unwaited adverse effect]
Semaglutides (Ozempic and Wegovy) are a class of molecules known as GLP-1 (Glucagon-like peptide 1) receptor agonists that mimic a hormone, GLP-1, in the body to increase the secretion of insulin, lower glucagon, control sugar spikes, and suppress appetite, leading to weight loss
Growth factor upregulation: The peptide stimulates vascular endothelial growth factor (VEGF) production and enhances the expression of growth hormone receptors, promoting angiogenesis and tissue repair
Glutamate acts on ionotropic and metabotropic (G-protein coupled) receptors
Common community options include adding cagrilintide for satiety, adding MOTS-c for mitochondrial support, or adding a GH secretagogue (covered in the Advanced Recomp Stack) for lean mass